Nano-X Imaging Ltd. (NNOX) stock
Close on Nov 12, 2026Market cap $22.16MP/E –Yield –
Nano-X Imaging Ltd. grew revenue 15.4% to $13.02M over fiscal 2025. Free cash flow was -$45.00M. At the latest close the market valued the company at $22.16M.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $22.16M
- P/E ratio
- –
- Price to sales
- 1.70
- Price to book
- 0.31
- Dividend yield
- –
- Free cash flow yield
- -203.09%
Fundamentals
- Revenue
- $13.02M
- Net income
- -$75.02M
- EPS, diluted
- -$1.16
- Free cash flow
- -$45.00M
- Book value per share
- $1036.28
- Diluted shares
- 0M
Trading
- Previous close
- $0.36
- Open
- $0.37
- Day's range
- $0.31 – $0.38
- Volume
- 2,715,501
- Average volume (20 days)
- 5,911,760
- Beta (5 years)
- 1.35
- 52-week range
- $0.21 – $4.71
- RSI (14 days)
- 39.6
- Volatility (1 year)
- 118.0%
- Relative volume
- 1.25×
- WACC
- 10.9%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NNOX | S&P 500 | Difference | NNOX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -37.6% | -2.7% | −34.9 pts | ||
| 3 months | -68.8% | -1.7% | −67.0 pts | ||
| Year to date | -88.6% | +11.9% | −100.5 pts | ||
| 1 year | -89.5% | +12.0% | −101.5 pts | ||
| 3 years | -94.3% | +78.2% | −172.5 pts | -61.6% | +21.2% |
| 5 years | -98.7% | +73.2% | −171.9 pts | -57.8% | +11.6% |
Nine years at a glance
Fiscal years 2017 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Nano-X Imaging filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About Nano-X Imaging
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Nano-X Imaging Ltd. is an initial launch-stage medical imaging technology company that develops and commercializes digital X-ray source technology. Its primary products include the Nanox.ARC and Nanox.ARC X, which are multi-source 3D digital tomosynthesis systems, alongside the cloud-based Nanox.CLOUD platform. The company also provides teleradiology services and artificial intelligence image-analysis decision-support solutions. Nanox pursues three commercial business models: a subscription-based pay-per-scan medical screening service, direct equipment capital sales, and original equipment manufacturer licensing. Its target customers and users include physicians, diagnostic testing centers, medical imaging providers, hospitals, urgent care operators, and large healthcare systems.
Company profile, executives and historyNano-X Imaging stock: common questions
What is Nano-X Imaging's stock price?
NNOX closed at $0.32 on Nov 12, 2026, down 12.50% on the day. Over the past 52 weeks it traded between $0.21 and $4.71.
What is Nano-X Imaging's market cap?
Nano-X Imaging was worth $22.16M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NNOX's P/E ratio?
Nano-X Imaging lost money over fiscal 2025 (diluted EPS -$1.16), so it has no meaningful P/E ratio.
How much revenue does Nano-X Imaging make?
Nano-X Imaging reported revenue of $13.02M for fiscal 2025, up 15.4% from a year earlier.
Does Nano-X Imaging pay a dividend?
No. Nano-X Imaging has not paid a cash dividend over the last twelve months.
How has NNOX stock performed over the past year?
Including dividends, NNOX returned -89.5% over the past year, against +12.0% for the S&P 500.
How many NNOX shares are sold short?
6M shares were sold short at the latest FINRA report, 9.28% of the float, or 5.9 days of average trading volume.
Who are Nano-X Imaging's competitors?
Companies most similar to Nano-X Imaging by business, industry and size include QTI, HYPR, ESMC, CV, PLSM.
See a number that looks wrong?